Thermo Fisher’s CDMO business Patheon will add 16,000 L of single-use capacity through a US$50 million (€41 million) expansion at its St Louis facility. Contract development and manufacturing organization (CDMO) Patheon will expand its St Louis, Missouri bioproduction site by 64,000 ft2 on the back of what it says is “extremely strong growth in demand”  for commercial biologic manufacturing. The facility was added to Patheon’s network through the 2014 acquisition of Gallus Biopharmaceuticals. The investment will not only add 16,000…